The Efficacy β-Alanine Supplementation in Performance Outcomes of Road Professional Endurance Cyclists

A Randomised Double-blind Clinical Trial to Analyse the Efficacy of Short-term β-Alanine Supplementation in Performance Outcomes of Road Professional Endurance Cyclists

A double-blind, placebo-controlled, randomised, with two arms (product and placebo) unicentric clinical trial to analyse the efficacy on physical performance parameters of a product designed for sport during a lapse of two weeks (7 days).

After recruitment, subject will be randomised and allocated to one group of the 2 study arms: treatment group or control group (placebo).

A simple randomisation will be performed using software by a random number generator, and assigned to participants.

Inclusion Criteria:

• Not respecting rest the day before physical tests.
• Not being in a fasted state (at least 2 h from last meal).
• Having consumed stimulants acutely before the trial, or under drug treatment affecting perceived effort of the trial.
• Not being available to perform every trial on the same conditions at the same time of the day.
• Not sticking to the same diet, 24 h before each trial.

Exclusion Criteria:

• Adverse event
• Protocol violation
• Lost to follow-up
• Allergy to any of the components of the treatment or placebo product. This includes allergy to β-alanine, wheat, soy, nuts (including peanuts), sesame and its byproducts.